Modern concepts on pathogenetic mechanisms of liver fibrosis

This review summarizes current data on the pathogenetic mechanisms of fibrosis in chronic liver diseases. Controlled inflammation and transdifferentiation of hepatic stellate cells into myofibroblasts is a key element of fibrogenesis, however, further study of the role of each of the macrophage popu...

Full description

Bibliographic Details
Published in:	Журнал инфектологии
Main Authors:	N. A. Efremova, V. A. Greshnyakova, L. G. Goryacheva
Format:	Article
Language:	Russian
Published:	Journal Infectology 2023-04-01
Subjects:	liver fibrosis pathogenesis of liver fibrosis stellate cells myofibroblasts mesenchymal stem cells cytokines mirna regeneration of liver fibrosis regression of liver fibrosis
Online Access:	https://journal.niidi.ru/jofin/article/view/1466

Similar Items

The effect of fucoxanthin on the development of CCl<sub>4</sub>-induced liver fibrosis
by: V. N. Slautin, et al.
Published: (2023-06-01)

Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis
by: Oliver Krenkel, et al.
Published: (2019-05-01)

Noncoding RNA-Mediated Epigenetic Regulation in Hepatic Stellate Cells of Liver Fibrosis
by: Ruoyu Gao, et al.
Published: (2024-08-01)

Cytoglobin as a Marker of Hepatic Stellate Cell-derived Myofibroblasts
by: Norifumi eKawada
Published: (2015-11-01)

Distribution of hepatic stellate cells and their role in the development of parasitic fibrosis and liver cirrhosis in domestic animals
by: Kukolj Vladimir, et al.
Published: (2015-01-01)

TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
by: Bedair Dewidar, et al.
Published: (2019-11-01)

“The Good, the Bad, and the Ugly” – About Diverse Phenotypes of Hepatic Stellate Cells in the LiverSummary
by: Alexandra Bogomolova, et al.
Published: (2024-01-01)

T cells and liver fibrosis
by: Ruonan Sun, et al.
Published: (2022-09-01)

Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression
by: Alessandra Caligiuri, et al.
Published: (2021-10-01)

Preclinical Models and Promising Pharmacotherapeutic Strategies in Liver Fibrosis: An Update
by: Tea Omanovic Kolaric, et al.
Published: (2023-05-01)

The Role of Mesothelial Cells in Liver Development, Injury, and Regeneration
Published: (2016-03-01)

Progress of researches on inducing hepatic stellate cell ferroptosis for treatment of liver fibrosis
by: SUN Lijie, HAO Dandan
Published: (2024-01-01)

Hepatic recruitment of myeloid-derived suppressor cells upon liver injury promotes both liver regeneration and fibrosis
by: Qiongwen Zhang, et al.
Published: (2024-05-01)

Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy
by: Hong Li, et al.
Published: (2023-07-01)

Editorial: Liver myofibroblasts
by: Jiri Kanta, et al.
Published: (2016-08-01)

Liver Fibrosis Leading to Cirrhosis: Basic Mechanisms and Clinical Perspectives
by: Kaumudi Somnay, et al.
Published: (2024-09-01)

Role of WISP1 in Stellate Cell Migration and Liver Fibrosis
by: Daniela González, et al.
Published: (2024-09-01)

RANKL inhibits activation of hepatic stellate cells during hepatic fibrosis in mice
by: ZHOU Lijia, et al.
Published: (2023-01-01)

The Role of Mesenchymal Stem Cells in Liver Regeneration
by: Hardian Gunardi
Published: (2023-08-01)

Myofibroblasts in Schistosomal Portal Fibrosis of Man
by: Andrade Zilton A, et al.
Published: (1999-01-01)

Involvement of epithelial-mesenchymal transition in liver fibrosis
by: Kangkang Yu, et al.
Published: (2018-01-01)

Human umbilical cord mesenchymal stem cells enhance liver regeneration and decrease collagen content in fibrosis mice after partial hepatectomy by activating Wnt/β-catenin signaling
by: Li Xuewei, et al.
Published: (2024-12-01)

Identification of miRNA-target gene regulatory networks in liver fibrosis based on bioinformatics analysis
by: Yang Tai, et al.
Published: (2021-08-01)

The Role of Butylidenephthalide in Targeting Microenvironment Contributes to the Ameliorate of Liver Fibrosis
by: Hong-Meng eChuang, et al.
Published: (2016-04-01)

Liver macrophage-derived exosomal miRNA-342-3p promotes liver fibrosis by inhibiting HPCAL1 in stellate cells
by: Wenshuai Li, et al.
Published: (2025-02-01)

Personalized Pain Pathways in Liver Fibrosis: Towards Precision Hepatology
by: Tamer A. Addissouky
Published: (2024-12-01)

Effect of T lymphocyte on hepatic stellate cell activation in liver fibrosis
by: GONG Xiaoqian, et al.
Published: (2025-04-01)

Role of macrophage-to-myofibroblast transition in chronic liver injury and liver fibrosis
by: Suhong Xia, et al.
Published: (2023-11-01)

Current strategies for targeted therapy of liver fibrosis
by: D. V. Garbuzenko
Published: (2022-10-01)

The Origin and Fate of Liver MyofibroblastsSummary
by: Hyun Young Kim, et al.
Published: (2024-01-01)

Genetic Characterization of Rat Hepatic Stellate Cell Line PAV-1
by: Kiara Gäberlein, et al.
Published: (2023-06-01)

Genetic Characterization of Rat Hepatic Stellate Cell Line HSC-T6 for In Vitro Cell Line Authentication
by: Indrajit Nanda, et al.
Published: (2022-05-01)

Rat Hepatic Stellate Cell Line CFSC-2G: Genetic Markers and Short Tandem Repeat Profile Useful for Cell Line Authentication
by: Indrajit Nanda, et al.
Published: (2022-09-01)

The role of PI3k/AKT signaling pathway in attenuating liver fibrosis: a comprehensive review
by: Emad Shamsan, et al.
Published: (2024-03-01)

Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Reversing Hepatic Fibrosis in 3D Liver Spheroids
by: Giulia Chiabotto, et al.
Published: (2024-08-01)

Carfilzomib shows therapeutic potential for reduction of liver fibrosis by targeting hepatic stellate cell activation
by: Ayana Fujiwara, et al.
Published: (2024-08-01)

Liver fibrosis as a predictor of liver failure and outcome following ALPPS among patients with primary liver cancer
by: Junwei Zhang, et al.
Published: (2024-07-01)

Application of mesenchymal stem cells in liver fibrosis and regeneration
by: Zhenyu Liu, et al.
Published: (2024-12-01)

Adipose-derived mesenchymal stem cells inhibit hepatic stellate cells activation to alleviate liver fibrosis via Hippo pathway
by: Haifeng Liu, et al.
Published: (2024-10-01)

MicroRNAs as critical regulators in liver fibrosis
by: Xiaolin Wang, et al.
Published: (2023-09-01)